Literature DB >> 19864419

HECT domain-containing E3 ubiquitin ligase Nedd4 interacts with and ubiquitinates Sprouty2.

Francis Edwin1, Kimberly Anderson, Tarun B Patel.   

Abstract

Sprouty (Spry) proteins are important regulators of receptor tyrosine kinase signaling in development and disease. Alterations in cellular Spry content have been associated with certain forms of cancers and also in cardiovascular diseases. Thus, understanding the mechanisms that regulate cellular Spry levels are important. Herein, we demonstrate that Spry1 and Spry2, but not Spry3 or Spry4, associate with the HECT domain family E3 ubiquitin ligase, Nedd4. The Spry2/Nedd4 association involves the WW domains of Nedd4 and requires phosphorylation of the Mnk2 kinase sites, Ser(112) and Ser(121), on Spry2. The phospho-Ser(112/121) region on Spry2 that binds WW domains of Nedd4 is a novel non-canonical WW domain binding region that does not contain Pro residues after phospho-Ser. Endogenous and overexpressed Nedd4 polyubiquitinate Spry2 via Lys(48) on ubiquitin and decrease its stability. Silencing of endogenous Nedd4 increased the cellular Spry2 content and attenuated fibroblast growth factor-elicited ERK1/2 activation that was reversed when elevations in Spry2 levels were prevented by Spry2-specific small interfering RNA. Mnk2 silencing decreased Spry2-Nedd4 interactions and also augmented the ability of Spry2 to inhibit fibroblast growth factor signaling. This is the first report demonstrating the regulation of cellular Spry content and its ability to modulate receptor tyrosine kinase signaling by a HECT domain-containing E3 ubiquitin ligase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864419      PMCID: PMC2804172          DOI: 10.1074/jbc.M109.030882

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Analysis of Nedd4 expression during skeletal development in the mouse limb.

Authors:  A D Weston; T M Underhill
Journal:  Mech Dev       Date:  2000-06       Impact factor: 1.882

Review 2.  NeW wrinkles for an old domain.

Authors:  M Sudol; T Hunter
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

3.  The C terminus of sprouty is important for modulation of cellular migration and proliferation.

Authors:  Y Yigzaw; L Cartin; S Pierre; K Scholich; T B Patel
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

4.  The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction.

Authors:  Deepali Bhandari; Seth L Robia; Adriano Marchese
Journal:  Mol Biol Cell       Date:  2008-12-30       Impact factor: 4.138

5.  Evidence for direct interaction between Sprouty and Cbl.

Authors:  E S Wong; J Lim; B C Low; Q Chen; G R Guy
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

6.  Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation.

Authors:  A Sasaki; T Taketomi; T Wakioka; R Kato; A Yoshimura
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

7.  Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation.

Authors:  I Gross; B Bassit; M Benezra; J D Licht
Journal:  J Biol Chem       Date:  2001-10-03       Impact factor: 5.157

Review 8.  Intermolecular interactions of Sprouty proteins and their implications in development and disease.

Authors:  Francis Edwin; Kimberly Anderson; Chunyi Ying; Tarun B Patel
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

9.  Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells.

Authors:  M A Impagnatiello; S Weitzer; G Gannon; A Compagni; M Cotten; G Christofori
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

10.  K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway.

Authors:  Elsa Lauwers; Christophe Jacob; Bruno André
Journal:  J Cell Biol       Date:  2009-04-27       Impact factor: 10.539

View more
  22 in total

1.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

2.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

Review 3.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

4.  Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.

Authors:  Takeshi Ueda; Masato Sasaki; Andrew J Elia; Iok In Christine Chio; Koichi Hamada; Rikiro Fukunaga; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  Exploring the Structural Mechanism of Covalently Bound E3 Ubiquitin Ligase: Catalytic or Allosteric Inhibition?

Authors:  Imane Bjij; Shama Khan; Robin Betz; Driss Cherqaoui; Mahmoud E S Soliman
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

6.  A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.

Authors:  Annamaria Milillo; Francesca La Carpia; Stefano Costanzi; Vanessa D'Urbano; Maurizio Martini; Paola Lanuti; Gisella Vischini; Luigi M Larocca; Marco Marchisio; Sebastiano Miscia; Antonio Amoroso; Fiorella Gurrieri; Eugenio Sangiorgi
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

7.  Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.

Authors:  Susie A Lee; Sara Ladu; Matthias Evert; Frank Dombrowski; Valentina De Murtas; Xin Chen; Diego F Calvisi
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

8.  Sprouty 2 binds ESCRT-II factor Eap20 and facilitates HIV-1 gag release.

Authors:  G N Medina; L S Ehrlich; M H Chen; M B Khan; M D Powell; C A Carter
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

9.  SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.

Authors:  A Barbáchano; A Fernández-Barral; F Pereira; M F Segura; P Ordóñez-Morán; E Carrillo-de Santa Pau; J M González-Sancho; D Hanniford; N Martínez; A Costales-Carrera; F X Real; H G Pálmer; J M Rojas; E Hernando; A Muñoz
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

10.  Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.

Authors:  Kristin C Hicks; Tarun B Patel
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.